XML 73 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Stock-based Compensation Expense
The Company recognized stock-based compensation expense in its Consolidated Financial Statements in 2023, 2022 and 2021 as follows:
202320222021
Stock-based compensation expense$31,308 $39,403 $41,451 
Less: Deferred tax benefit(5,989)(7,340)(8,444)
Stock-based compensation expense, net of tax$25,319 $32,063 $33,007 
Schedule of Assumptions Used in the Weighted Average Fair Value of the Stock Options Granted
The weighted average fair value of the Company’s stock options granted during 2023, 2022 and 2021 were $15.70, $17.95 and $14.94, respectively, using the following assumptions:
202320222021
Expected term (in years)5.325.845.60
Expected volatility24.32 %27.79 %28.67 %
Expected dividend yield1.49 %1.40 %1.30 %
Risk-free interest rate3.95 %3.79 %1.37 %
Schedule of Stock Option Plans
This table presents certain information relating to the Company’s stock option plans for 2023, 2022 and 2021:
Number of
Shares
Weighted
Average Price
Balance as of December 31, 202018,495,000 $51.15 
Granted3,323,000 60.48 
Exercised(1,719,000)29.73 
Expired or canceled(1,015,000)57.92 
Balance as of December 31, 202119,084,000 $54.35 
Granted2,215,000 61.74 
Exercised(1,537,000)35.03 
Expired or canceled(992,000)59.52 
Balance as of December 31, 202218,770,000 $56.52 
Granted1,871,000 62.01 
Exercised(2,148,000)45.11 
Expired or canceled(1,073,000)59.79 
Balance as of December 31, 202317,420,000 $58.31 
Exercisable as of December 31, 20236,759,000 $54.95 
Available for future grant as of December 31, 20238,509,000 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
This table presents certain information relating to the Company’s RSUs for 2023 and 2022:
Number of
RSUs
Weighted
Average Grant-Date Fair Value
Balance as of December 31, 2021— $— 
Granted467,000 61.27 
Vested— — 
Expired or canceled— — 
Balance as of December 31, 2022467,000 $61.27 
Granted373,000 61.76 
Vested(20,000)57.39 
Expired or canceled(24,000)61.85 
Balance as of December 31, 2023796,000 $61.58 
Schedule of Common Stock Buyback The following table provides the total number of shares repurchased and the related total costs in 2023, 2022 and 2021:
YearTotal Number of
Shares Repurchased
Total Cost
20235,237,000 $310,769 
20225,914,000 338,442 
20216,747,000 411,534